NASDAQ · Financial Statements
Protara Therapeutics, Inc. (TARA) Financial Statements
$2.72
NASDAQ: TARA
Market Cap $152.59M
Overview Financials Dividend Protara Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-57.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-47.0M $-67.0M $-44.0M $-49.0M $-65.0M Net Profit $-47.0M $-66.0M $-40.0M $-45.0M $-57.0M EPS $-4.20 $-5.86 $-3.57 $-2.17 $-1.34 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $173.0M $113.0M $79.0M $181.0M $209.0M Total Liabilities $11.0M $11.0M $11.0M $14.0M $13.0M Cash $36.0M $24.0M $40.0M $163.0M $50.0M Borrowings $7.0M $6.0M $5.0M $4.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-35.0M $-26.0M $-38.0M $-36.0M $-56.0M Investing Cash Flow $-99.0M $15.0M $53.0M $19.0M $-140.0M Financing Cash Flow $0 $0 $0 $4.0M $0 Net Cash Flow $-133.0M $-12.0M $15.0M $123.0M $-113.0M Free Cash Flow $-35.0M $-27.0M $-38.0M $-36.0M $-56.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.12 EV / EBITDA -1.97 FCF Yield -42.94% Quick Ratio 10.97 Interest Coverage 0.00 Return 1Y 19.17% Return 3Y 37.88% Return 5Y -51.77%
Screens featuring this stock